GoPath Diagnostics
@GoPathLabs
Followers
198
Following
172
Media
416
Statuses
718
Full-service cancer genetics, molecular and anatomic pathology diagnostics laboratory.
Buffalo Grove, IL
Joined March 2017
Diabetes is a complex condition affecting millions across all ages and backgrounds, including rare forms like MODY that require specialized diagnosis and care. Early detection and awareness are vital, as many remain undiagnosed or face challenges managing their health.
0
0
1
We’re live at AMP 2025 in Boston! Stop by booth 1110 to learn more about our OncoTarget Series and how our comprehensive genomic profiling supports precision oncology. We are excited to connect with so many experts driving advancements in molecular diagnostics!
0
0
0
Meet Mya, who was diagnosed with a rare form of diabetes (HNF1A MODY) at just age ten. An early diagnosis gave her the knowledge and skills to advocate for herself & educate others about #MODY. https://t.co/RNiSn31oLc
#DiabetesAwarenessMonth #GeneticTesting
uchicagomedicine.org
Mya Abuzir is now a college student living with HNF1A MODY, a rare form of diabetes caused by a mutation in a single gene.
0
0
1
This #DiabetesAwarenessMonth, understanding your genetic risk for diabetes has never been easier. #DiabetesNow delivers accurate insights that support clearer diagnosis & risk assessment for people with atypical diabetes or a family history. 🔗 https://t.co/zZ3QWtgXy9
0
0
0
We’re live at the 2025 @UrologyUS Annual Meeting! Visit booth 410 and learn how our genomic and genetic testing solutions help urologists deliver precise, data-driven care. #LUGPA2025
0
1
1
What if the diagnosis you’ve lived with for years wasn’t the right one? For one family, the answer came through our #DiabetesNow™ genetic panel. The results revealed the cause of their diabetes, a rare inherited form known as #MODY. 🔗 https://t.co/uWbWQxsP38
#DiabetesAwareness
endeavorhealth.org
Pictured above: The Acevedo De Arias family with Liana Billings, MD, at Endeavor Health.
0
0
0
As Breast Cancer Awareness Month concludes, we remain committed to supporting clinicians and patients with comprehensive hereditary cancer testing. Awareness saves lives—knowledge changes care. #BreastCancerAwareness #KnowYourGenes
0
0
0
From the Freedom Trail to the future of molecular testing—Boston, we’re coming your way! Join us at booth 1110 during the AMP 2025 Annual Meeting & Expo to explore our OncoTarget Series & see how precision genomic profiling is transforming advanced cancer care.
0
0
0
After a history of breast cancer in her family, Danielle pursued genetic testing & learned she carried a mutation. The results revealed early-stage breast cancer, allowing her to begin treatment before the disease could progress. Read more from the @NBCF:
nationalbreastcancer.org
Genetic testing revealed a BRCA gene mutation for Danielle and her twin sister. Danielle's decision to be proactive may have saved her life.
0
0
1
Still handling prostate biopsy cores the old way? There’s a better solution. Visit us at our pop-up at @GoPathLabs’ booth #410 during the LUGPA Annual Meeting to see how TWO-D simplifies tissue handling from start to finish—reduces steps, saves time, & prevents fragmentation.
0
1
1
Breast cancer remains a leading health concern for women in the U.S. 1 in 8 women will face a diagnosis in their lifetime, & rates continue to rise in certain age groups. This #BreastCancerAwareness, we’re sharing the numbers that matter. #CancerGenomics
1
0
0
👨👩👧 When should discussions about hereditary risk ideally begin? 💬 Tell us when you think genetic risk conversations should happen. #HereditaryCancer
0
0
0
Join us at the 2025 @UrologyUS Annual Meeting to see how our latest genomic and genetic testing solutions are helping urologists deliver more precise, data-driven care. Our solutions include: ✅ PROSTATENOW ✅ OncoTarget 500 ✅ Integrated Genomic Tools
0
1
2
B. Germline genetic testing ✅ Germline genetic testing is most useful for patients with a strong family history of breast or ovarian cancer because it identifies inherited gene variants that significantly increase cancer risk & can guide early screening & prevention strategies.
0
0
0
🧬 For patients with a strong family history of breast or ovarian cancer, which test is most useful for risk assessment? (View the comment section for the answer and explanation) #BreastCancerAwareness #KnowYourGenes
1
0
0
From lobsters to labs, Boston, we’re ready to showcase what’s next in molecular testing! We're excited to be attending the AMP 2025 Annual Meeting & Expo in Boston! Visit us at booth 1110 to learn more about our OncoTarget Series, molecular testing, and biopharma programs.
0
0
0
💗 When Sarah first felt a lump, she never imagined it would lead to both a breast cancer diagnosis & the discovery of a BRCA1 gene mutation. Her story reminds us that awareness and knowledge can save lives. Learn more from the @CDCgov:
cdc.gov
Personal stories from people with hereditary breast cancer.
0
0
0
October reminds us that #breastcancer risk isn’t only environmental or sporadic; some cases are hereditary. Genetic testing helps clinicians pinpoint those who may benefit from earlier or more frequent screening.
0
0
0
We’re excited to be back in Chicago for the 2025 LUGPA Annual Meeting! Visit us at booth 410 to explore our ProstateNow Germline Panel, designed to support precision & efficiency in urology practices.
0
0
1